Literature DB >> 8931312

Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach.

Y Torii1, K Hitomi, Y Yamagishi, N Tsukagoshi.   

Abstract

MC3T3-E1 cells grown with ascorbic acid express sequentially osteoblastic marker proteins such as alkaline phosphatase (ALPase) and then form a mineralized extracellular matrix (ECM) as a consequence of osteoblastic differentiation. To explore the functional roles of ALPase in the process of osteoblastic maturation, an inducible expression vector for antisense ALPase RNA was constructed and stably transfected into MC3T3-E1 cells. The expression of antisense ALPase RNA in the differentiated MC3T3-E1 transfectants reduced markedly the ALPase activity, which resulted in a significant decrease in the deposition of minerals upon prolonged culture. These findings demonstrated directly that ALPase participated in the mineralization of ECM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931312     DOI: 10.1006/cbir.1996.0060

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  10 in total

Review 1.  Cell culture systems for studies of bone and tooth mineralization.

Authors:  Adele L Boskey; Rani Roy
Journal:  Chem Rev       Date:  2008-09-19       Impact factor: 60.622

2.  Appearance of cell-adhesion factor in osteoblast proliferation and differentiation of apatite coating titanium by blast coating method.

Authors:  Hirotsugu Umeda; Takamitsu Mano; Koji Harada; Ferdous Tarannum; Yoshiya Ueyama
Journal:  J Mater Sci Mater Med       Date:  2017-06-15       Impact factor: 3.896

3.  Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling really important?

Authors:  J Costa-Rodrigues; C A Teixeira; M H Fernandes
Journal:  Clin Exp Metastasis       Date:  2011-04-09       Impact factor: 5.150

4.  The effects of low dose X-irradiation on osteoblastic MC3T3-E1 cells in vitro.

Authors:  Wei Xu; Lan Xu; Ming Chen; Yong Tao Mao; Zong Gang Xie; Shi Liang Wu; Qi Rong Dong
Journal:  BMC Musculoskelet Disord       Date:  2012-06-08       Impact factor: 2.362

5.  Antimicrobial Properties and Cytocompatibility of PLGA/Ag Nanocomposites.

Authors:  Mariangela Scavone; Ilaria Armentano; Elena Fortunati; Francesco Cristofaro; Samantha Mattioli; Luigi Torre; Jose M Kenny; Marcello Imbriani; Carla Renata Arciola; Livia Visai
Journal:  Materials (Basel)       Date:  2016-01-11       Impact factor: 3.623

6.  Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.

Authors:  Zai Hang Zhang; Xin Yu Jia; Jing Yi Fang; Hao Chai; Qun Huang; Chang She; Peng Jia; De Chun Geng; Wei Xu
Journal:  J Cell Mol Med       Date:  2020-03-05       Impact factor: 5.310

7.  Combined Effects of Proton Radiation and Simulated Microgravity on the Cell Viability and ALP Activity of Murine Osteoblast Cells.

Authors:  Liqiu Ma; Fuquan Kong; Yihao Gong; Qiaojuan Wang; Jiancheng Liu; Li Sui
Journal:  Front Public Health       Date:  2021-11-30

8.  Osteocytic cells exposed to titanium particles increase sclerostin expression and inhibit osteoblastic cell differentiation mostly via direct cell-to-cell contact.

Authors:  Hao Chai; Zai Hang Zhang; Jing Yi Fang; Chang She; De Chun Geng; Wei Xu
Journal:  J Cell Mol Med       Date:  2022-06-28       Impact factor: 5.295

9.  A comparative analysis of the in vitro effects of pulsed electromagnetic field treatment on osteogenic differentiation of two different mesenchymal cell lineages.

Authors:  Gabriele Ceccarelli; Nora Bloise; Melissa Mantelli; Giulia Gastaldi; Lorenzo Fassina; Maria Gabriella Cusella De Angelis; Davide Ferrari; Marcello Imbriani; Livia Visai
Journal:  Biores Open Access       Date:  2013-08

10.  Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts.

Authors:  Tanja Niedermair; Stephan Schirner; Raphael Seebröker; Rainer H Straub; Susanne Grässel
Journal:  Sci Rep       Date:  2018-06-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.